Literature DB >> 4061812

Preparation and high-performance liquid chromatography of 3'-phosphoadenosine-5'-phospho[35S]sulfate with a predetermined specific activity.

D M Delfert, H E Conrad.   

Abstract

3'-Phosphoadenosine-5'-phospho[35S]sulfate (PAP35S) was prepared by incubating ATP and carrier-free H2(35)SO4 with a 100,000g supernatant fraction prepared from chick embryo chondrocytes. The product was partially purified by paper electrophoresis and mixed with unlabeled PAPS to give a solution of PAP35S with a specific activity and a concentration approximating those required for the desired metabolic studies. The product was analyzed by high-performance liquid chromatography on an anion-exchange column to determine the proportion of the 35SO4 cpm and A260 material found in the PAPS and other contaminating nucleotides. The PAP35S was purified further by preparative high-performance liquid chromatography. The exact specific activity of the PAP35S was then determined by using this PAP35S preparation as the SO4 donor in a sulfotransferase reaction using a microsomal preparation from the chick embryo chondrocytes as the enzyme and an 3H-labeled oligosaccharide as the SO4 acceptor. The sulfated oligosaccharide was then isolated and the number of 3H and 35SO4 counts per minute in this product were used to calculate the specific activity of the donor. The features of this generally useful approach for preparing PAP35S of any desired specific activity and concentration are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4061812     DOI: 10.1016/0003-2697(85)90233-7

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  7 in total

1.  Biosynthesis of heparan sulphate with diverse structures and functions: two alternatively spliced forms of human heparan sulphate 6-O-sulphotransferase-2 having different expression patterns and properties.

Authors:  Hiroko Habuchi; Goichiro Miyake; Ken Nogami; Asato Kuroiwa; Yoichi Matsuda; Marion Kusche-Gullberg; Osami Habuchi; Masayuki Tanaka; Koji Kimata
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

2.  Mice deficient in N-acetylgalactosamine 4-sulfate 6-o-sulfotransferase are unable to synthesize chondroitin/dermatan sulfate containing N-acetylgalactosamine 4,6-bissulfate residues and exhibit decreased protease activity in bone marrow-derived mast cells.

Authors:  Shiori Ohtake-Niimi; Sachiko Kondo; Tatsuro Ito; Saori Kakehi; Tadayuki Ohta; Hiroko Habuchi; Koji Kimata; Osami Habuchi
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

3.  Preparation of chondroitin sulfate libraries containing disulfated disaccharide units and inhibition of thrombin by these chondroitin sulfates.

Authors:  Mario Numakura; Noriko Kusakabe; Kazuya Ishige; Shiori Ohtake-Niimi; Hiroko Habuchi; Osami Habuchi
Journal:  Glycoconj J       Date:  2010-05-14       Impact factor: 2.916

4.  N-linked oligosaccharides are required to produce and stabilize the active form of chondroitin 4-sulphotransferase-1.

Authors:  Akiko Yusa; Ken Kitajima; Osami Habuchi
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

5.  Substrate specificities of mouse heparan sulphate glucosaminyl 6-O-sulphotransferases.

Authors:  Emanuel Smeds; Hiroko Habuchi; Anh-Tri Do; Eva Hjertson; Helena Grundberg; Koji Kimata; Ulf Lindahl; Marion Kusche-Gullberg
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

6.  Inhibition of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase by beta-D-4-O-sulfo-N-acetylgalactosaminides bearing various hydrophobic aglycons.

Authors:  Hiroko Nozaki; Yuri Tomoyama; Hideyuki Takagi; Koutaro Yokoyama; Chika Yamada; Ken-ichi Kaio; Masaki Tsukimori; Kazuya Nagao; Yuya Itakura; Shiori Ohtake-Niimi; Hirofumi Nakano; Osami Habuchi
Journal:  Glycoconj J       Date:  2009-12-18       Impact factor: 2.916

7.  Chondroitin 4-sulphotransferase-1 and chondroitin 6-sulphotransferase-1 are affected differently by uronic acid residues neighbouring the acceptor GalNAc residues.

Authors:  Takayoshi Yamada; Shiori Ohtake; Makoto Sato; Osami Habuchi
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.